Summary
This 8-K filing from UnitedHealth Group Incorporated (UNH), dated January 4, 2007, reports on an event that occurred on December 29, 2006. The primary purpose of this filing is to disclose that certain current and former executives have entered into an options repricing agreement with the Company. This action was taken to comply with Section 409A of the Internal Revenue Code, which addresses potential surtax liabilities on deferred compensation, and to take advantage of transitional rules provided by the Treasury Department. While the filing itself does not detail the specifics of the repricing, it signals a proactive measure by the company and its executives to manage tax implications related to stock options. Investors should note that this event relates to historical option grants and their alignment with new tax regulations, rather than an immediate operational or financial performance change. Further details on the terms of the repricing would typically be found in subsequent filings or company disclosures.
Key Highlights
- 1Disclosure of options repricing agreements for certain current and former executives.
- 2The repricing is intended to address potential surtax liability under Section 409A of the Internal Revenue Code.
- 3The action complies with transitional rules permitted by the Treasury Department for Section 409A.
- 4Key executives involved include Stephen J. Hemsley, David S. Wichmann, Lois E. Quam, and former CEO William W. McGuire, M.D.
- 5The event date reported is December 29, 2006, with the filing date being January 3, 2007.
- 6This filing is made under Item 5.02 of Form 8-K, concerning departures or appointments of officers and directors, and compensatory arrangements.